Oncology Research and Treatment

Original Article · Originalarbeit

Presence of Symptom Distress and Prostate Cancer-Related Anxiety in Patients at the Beginning of Cancer Rehabilitation

Mehnert A.a · Lehmann C.a · Schulte T.b · Koch U.a

Author affiliations

aDepartment of Medical Psychology, University Medical Center Hamburg-Eppendorf, bKlinik Bad Oexen, Bad Oeynhausen, Germany

Related Articles for ""

Onkologie 2007;30:551-556

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Article · Originalarbeit

Published online: October 16, 2007
Issue release date: November 2007

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0

ISSN: 2296-5270 (Print)
eISSN: 2296-5262 (Online)

For additional information: https://www.karger.com/ORT

Abstract

Background: A growing body of research points towards a substantial number of prostate cancer patients experiencing distress and anxiety. This study examines the frequency and character of cancer- and treatment-related problems and its association with symptom distress and prostate cancer-related anxiety in patients at the beginning of an oncological rehabilitation programm. Patients and Methods: 197 prostate cancer patients who had undergone prostatectomy (92.5% participation rate) completed the Memorial Anxiety Scale for Prostate Cancer (MAX-PC), the NCCN Distress Thermometer and EORTC QLQ-C30 subscales emotional function and global quality of life. Results: 88% of patients report cancer- or treatment-related problems with a mean of 5 problems, and 104 patients (53%) experience distress and/or prostate cancer-related anxiety. The most prevalent symptoms are changes in urination, sexual problems, difficulties getting around, pain, fatigue and sleep problems. Emotional problems such as nervousness, worries, fears and sadnessness are prevalent in at least 53% of patients. Patients with distress and anxiety are confronted with a higher number and a wider range of problems and experience significantly lower levels of quality of life. Conclusion: Findings emphasize the role of cancer rehabilitation and underline the importance of psychosocial screening measures and the provision of psychosocial support in prostate cancer patients.




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Original Article · Originalarbeit

Published online: October 16, 2007
Issue release date: November 2007

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 0

ISSN: 2296-5270 (Print)
eISSN: 2296-5262 (Online)

For additional information: https://www.karger.com/ORT


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP